125 related articles for article (PubMed ID: 38174975)
21. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
22. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
23. Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening.
Machens A; Dralle H
Eur J Endocrinol; 2016 Sep; 175(3):219-28. PubMed ID: 27334331
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
25. Surgical Treatment of Medullary Thyroid Cancer.
Machens A; Dralle H
Recent Results Cancer Res; 2015; 204():187-205. PubMed ID: 26494390
[TBL] [Abstract][Full Text] [Related]
26. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades.
Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR
Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969
[No Abstract] [Full Text] [Related]
27. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
[TBL] [Abstract][Full Text] [Related]
28. Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma.
Franc S; Niccoli-Sire P; Cohen R; Bardet S; Maes B; Murat A; Krivitzky A; Modigliani E;
Clin Endocrinol (Oxf); 2001 Sep; 55(3):403-9. PubMed ID: 11589685
[TBL] [Abstract][Full Text] [Related]
29. Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.
Hamdy O; Awny S; Metwally IH
Ann R Coll Surg Engl; 2020 Sep; 102(7):499-503. PubMed ID: 32233867
[TBL] [Abstract][Full Text] [Related]
30. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
[No Abstract] [Full Text] [Related]
31. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
[TBL] [Abstract][Full Text] [Related]
32. Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer.
Greenblatt DY; Elson D; Mack E; Chen H
Asian J Surg; 2007 Apr; 30(2):108-12. PubMed ID: 17475579
[TBL] [Abstract][Full Text] [Related]
33. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
Nilubol N; Zhang L; Kebebew E
Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
[TBL] [Abstract][Full Text] [Related]
34. PROGNOSTIC VARIABLES AFFECTING PRIMARY TREATMENT OUTCOME FOR MEDULLARY THYROID CANCER.
Momin S; Chute D; Burkey B; Scharpf J
Endocr Pract; 2017 Sep; 23(9):1053-1058. PubMed ID: 28683235
[TBL] [Abstract][Full Text] [Related]
35. Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
J Clin Endocrinol Metab; 2014 Aug; 99(8):2986-94. PubMed ID: 24840813
[TBL] [Abstract][Full Text] [Related]
36. Sporadic medullary microcarcinoma of the thyroid: a retrospective analysis of eighty cases.
Beressi N; Campos JM; Beressi JP; Franc B; Niccoli-Sire P; Conte-Devolx B; Murat A; Caron P; Baldet L; Kraimps JL; Cohen R; Bigorgne JC; Chabre O; Lecomte P; Modigliani E
Thyroid; 1998 Nov; 8(11):1039-44. PubMed ID: 9848720
[TBL] [Abstract][Full Text] [Related]
37. Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.
Machens A; Kaatzsch P; Lorenz K; Horn LC; Wickenhauser C; Schmid KW; Dralle H; Siebolts U
Surgery; 2022 Feb; 171(2):360-367. PubMed ID: 34602296
[TBL] [Abstract][Full Text] [Related]
38. Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid Cancer.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2021 Sep; 53(9):588-593. PubMed ID: 34496409
[TBL] [Abstract][Full Text] [Related]
39. Excellent prognosis of patients with nonhereditary medullary thyroid carcinoma with ultrasonographic findings of follicular tumor or benign nodule.
Fukushima M; Ito Y; Hirokawa M; Miya A; Kobayashi K; Akasu H; Shimizu K; Miyauchi A
World J Surg; 2009 May; 33(5):963-8. PubMed ID: 19198929
[TBL] [Abstract][Full Text] [Related]
40. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
